- Home
- ANNA vs CATX Comparison
ANNA vs CATX Comparison
Compare ANNA & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNA
- CATX
- Stock Information
- Founded
- ANNA 2007
- CATX 1983
- Country
- ANNA United States
- CATX United States
- Employees
- ANNA N/A
- CATX N/A
- Industry
- ANNA
- CATX Medical/Dental Instruments
- Sector
- ANNA
- CATX Health Care
- Exchange
- ANNA NYSE
- CATX Nasdaq
- Market Cap
- ANNA 215.9M
- CATX 239.0M
- IPO Year
- ANNA N/A
- CATX N/A
- Fundamental
- Price
- ANNA $5.31
- CATX $3.67
- Analyst Decision
- ANNA
- CATX Strong Buy
- Analyst Count
- ANNA 0
- CATX 11
- Target Price
- ANNA N/A
- CATX $12.90
- AVG Volume (30 Days)
- ANNA 31.9K
- CATX 954.5K
- Earning Date
- ANNA 08-15-2025
- CATX 08-13-2025
- Dividend Yield
- ANNA N/A
- CATX N/A
- EPS Growth
- ANNA N/A
- CATX N/A
- EPS
- ANNA N/A
- CATX N/A
- Revenue
- ANNA $2,064,630.00
- CATX $1,471,000.00
- Revenue This Year
- ANNA N/A
- CATX N/A
- Revenue Next Year
- ANNA N/A
- CATX $11.99
- P/E Ratio
- ANNA N/A
- CATX N/A
- Revenue Growth
- ANNA N/A
- CATX N/A
- 52 Week Low
- ANNA $4.36
- CATX $1.60
- 52 Week High
- ANNA $18.70
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- ANNA N/A
- CATX 44.88
- Support Level
- ANNA N/A
- CATX $3.88
- Resistance Level
- ANNA N/A
- CATX $4.28
- Average True Range (ATR)
- ANNA 0.00
- CATX 0.27
- MACD
- ANNA 0.00
- CATX -0.08
- Stochastic Oscillator
- ANNA 0.00
- CATX 2.32
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy. It is also involved in drilling, testing, and tie-in-related activities associated with three incremental Longanesi development wells.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.